BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23165994)

  • 1. A new in vivo model to analyze hepatic metastasis of the human colon cancer cell line HCT116 in NOD/Shi-scid/IL-2Rγ(null) (NOG) mice by (18)F-FDG PET/CT.
    Kawai K; Tamura K; Sakata I; Ishida J; Nagata M; Tsukada H; Suemizu H; Nakamura M; Abe Y; Chijiwa T
    Oncol Rep; 2013 Feb; 29(2):464-8. PubMed ID: 23165994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI and FDG PET/CT findings of hepatic epithelioid hemangioendothelioma.
    Dong A; Dong H; Wang Y; Gong J; Lu J; Zuo C
    Clin Nucl Med; 2013 Feb; 38(2):e66-73. PubMed ID: 22996250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of FDG PET/CT and enhanced multi-detector CT for detecting liver metastasis according to the size and location.
    Park JM; Kim IY; Kim SW; Lee SM; Kim HG; Kim SY; Shin HC
    Ann Nucl Med; 2013 Apr; 27(3):217-24. PubMed ID: 23242953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in patients with liver metastases from uveal melanoma: results from a pilot study.
    Orcurto V; Denys A; Voelter V; Schalenbourg A; Schnyder P; Zografos L; Leyvraz S; Delaloye AB; Prior JO
    Melanoma Res; 2012 Feb; 22(1):63-9. PubMed ID: 22027909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a key molecular regulator of liver metastasis in human pancreatic carcinoma using a novel quantitative model of metastasis in NOD/SCID/gammacnull (NOG) mice.
    Suemizu H; Monnai M; Ohnishi Y; Ito M; Tamaoki N; Nakamura M
    Int J Oncol; 2007 Oct; 31(4):741-51. PubMed ID: 17786304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver metastasis models of colon cancer for evaluation of drug efficacy using NOD/Shi-scid IL2Rgammanull (NOG) mice.
    Hamada K; Monnai M; Kawai K; Nishime C; Kito C; Miyazaki N; Ohnishi Y; Nakamura M; Suemizu H
    Int J Oncol; 2008 Jan; 32(1):153-9. PubMed ID: 18097554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dual-time point images of the liver with (18)F-FDG PET/CT in suspected recurrence from colorectal cancer].
    Fuster D; Lafuente S; Setoain X; Navales I; Perissinotti A; Pavia J; Paredes P; Lomeña F; Pons F
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):111-6. PubMed ID: 22154291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-FLT PET/CT imaging is not competent for the pretreatment evaluation of metastatic gastric cancer: a comparison with 18F-FDG PET/CT imaging.
    Zhou M; Wang C; Hu S; Zhang Y; Yao Z; Li J; Guo W; Zhang Y
    Nucl Med Commun; 2013 Jul; 34(7):694-700. PubMed ID: 23604223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-FDG PET/CT predicts survival after radioembolization of hepatic metastases from breast cancer.
    Haug AR; Tiega Donfack BP; Trumm C; Zech CJ; Michl M; Laubender RP; Uebleis C; Bartenstein P; Heinemann V; Hacker M
    J Nucl Med; 2012 Mar; 53(3):371-7. PubMed ID: 22331219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
    Ho CL; Chen S; Yeung DW; Cheng TK
    J Nucl Med; 2007 Jun; 48(6):902-9. PubMed ID: 17504862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG PET/CT as a prognostic test after 90Y radioembolization in patients with metastatic hepatic disease.
    Zalom M; Yu R; Friedman M; Bresee C; Waxman A
    Clin Nucl Med; 2012 Sep; 37(9):862-5. PubMed ID: 22889775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A stepwise approach using metabolic volume and SUVmax to differentiate malignancy and dysplasia from benign colonic uptakes on 18F-FDG PET/CT.
    Oh JR; Min JJ; Song HC; Chong A; Kim GE; Choi C; Seo JH; Bom HS
    Clin Nucl Med; 2012 Jun; 37(6):e134-40. PubMed ID: 22614211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardized uptake values for [¹⁸F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI.
    Heusch P; Buchbender C; Beiderwellen K; Nensa F; Hartung-Knemeyer V; Lauenstein TC; Bockisch A; Forsting M; Antoch G; Heusner TA
    Eur J Radiol; 2013 May; 82(5):870-6. PubMed ID: 23394765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of virtual 18F-FDG PET/CT bronchoscopy for the detection of lymph node metastases in non-small cell lung cancer patients.
    Herbrik M; Treffert J; Geiger B; Riegger C; Hartung V; Rosenbaum-Krumme SJ; Forsting M; Antoch G; Heusner TA
    J Nucl Med; 2011 Oct; 52(10):1520-5. PubMed ID: 21908390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophilic infiltration in the colon and liver mimicking primary colon cancer with hepatic metastases on (18)F-FDG PET/CT.
    Jo I; Won KS; Choi BW; Kim SH; Zeon SK
    Clin Nucl Med; 2013 Jun; 38(6):471-3. PubMed ID: 23510892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic value of (18)F-FDG PET/CT imaging plus serum tumor marker assays for pulmonary lesions and clinical significance of SUVmax].
    Zhang TM; Zhang LM; Liu Y; Zhang ZF; Wang CL
    Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(41):2901-4. PubMed ID: 23328236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translational 18F-FDG PET/CT imaging to monitor lesion activity in intestinal inflammation.
    Bettenworth D; Reuter S; Hermann S; Weckesser M; Kerstiens L; Stratis A; Nowacki TM; Ross M; Lenze F; Edemir B; Maaser C; Pap T; Koschmieder S; Heidemann J; Schäfers M; Lügering A
    J Nucl Med; 2013 May; 54(5):748-55. PubMed ID: 23516311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic adenomatosis may mimic metastatic lesions of liver with 18F-FDG PET/CT.
    Sanli Y; Bakir B; Kuyumcu S; Ozkan ZG; Gulluoglu M; Bilge O; Turkmen C; Mudun A
    Clin Nucl Med; 2012 Jul; 37(7):697-8. PubMed ID: 22691518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial experience in small animal tumor imaging with a clinical positron emission tomography/computed tomography scanner using 2-[F-18]fluoro-2-deoxy-D-glucose.
    Tatsumi M; Nakamoto Y; Traughber B; Marshall LT; Geschwind JF; Wahl RL
    Cancer Res; 2003 Oct; 63(19):6252-7. PubMed ID: 14559811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [18F]Fluorodeoxyglucose positron emission tomography surveillance of hepatic metastases from prostate cancer following radiofrequency ablation: a case report.
    Ludwig V; Hopper OW; Martin WH; Kikkawa R; Delbeke D
    Am Surg; 2003 Jul; 69(7):593-8. PubMed ID: 12889623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.